Webcast/CME - Prostate Cancer: Recent Developments Relevant for Internal Medicine Physicians

	Unregistered User Click here if this is not your Personal Edition
		Contact Us \| Free E-Mail Updates \| Journals \| Register a colleague

Prostate Cancer

EXPLORE :

Most Read News

All Webcasts / CME

Warning | Privacy

Recent webcasts/CME - Prostate Cancer

	Primary Care Update in Urology
	Emerging Research May Improve Prostate Cancer Treatment

Recent news - Prostate Cancer

	TopAbstracts in Prostate Cancer 12/09/2009 - (DGNews)
	Men Taking ADT at Higher Risk for Heart Disease, Diabetes Regardless of Age - (DGNews)
	Medroxyprogesterone Most Effective Hormone Therapy for Reducing Hot Flushes in Men With Prostate Cancer - (DGNews)
	PSA Value 2 Years Post-Radiation Predicts Long-Term Survival in Prostate Cancer Patients - (DGNews)
	Quality of life three years after diagnosis of localised prostate cancer: population based cohort study - (BMJ)

Recent cases - Prostate Cancer

	Coexistence Of Pernicious Anemia And Prostate Cancer - 'An Experiment Of Nature' Involving Vitamin B12 Modulation Of Prostate Cancer Growth And Metabolism: A Case Report
	Incidental Carcinoma of the Prostate Gland Presenting with Initial Manifestation of Disseminated Intravascular Coagulopathy (Dic) in a Middle Aged Man: A Case Report
	Non-Prostatic Pathology on Prostate Needle-Biopsy - Colorectal Carcinoid: A Case Report
	A 70-Year-Old Male Having Advanced Prostate Cancer Presenting with Hypercalcemia and Diffuse Osteoblastic Bone Metastases: A Case Report
	A Dramatic, Objective Antiandrogen Withdrawal Response: Case Report and Review of the Literature

personal edition > prostate cancer > webcasts/CME

Webcasts/CME

E-Mail this webcast/CME to a colleague

Prostate Cancer: Recent Developments Relevant for Internal Medicine Physicians

Presented by:	The Cleveland Clinic Foundation Center for Continuing Education
Lecturer	William D. Carey, MD and Robert Dreicer, MD, MS, FACP
Approximate duration:	1 hr.
Summary points:	In this audiovisual CME activity, an expert in oncology analyses the implications of new screening date for prostate cancer and contrasts the risks and benefits of androgen deprivation therapy for non-metastatic prostate cancer.
Accreditation:	The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Cleveland Clinic Foundation Center for Continuing Education designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit. Expiration Date: October 9, 2010.
Other:

Additional Information